Related Experiment Video
Updated: May 2, 2026
09:50
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
Published on: November 2, 2019
7.6K
Chronic oedema/lymphoedema: under-recognised and under-treated.
David H Keast1, Marc Despatis2, Jill O Allen3
1Aging, Rehabilitation and Geriatric Care Research Centre, Lawson Health Research Institute, St. Joseph's Parkwood Hospital, London, Ontario, Canada.
International Wound Journal
|March 13, 2014
Summary
Chronic oedema/lymphoedema affects many Canadians, particularly cancer patients and those with obesity. Early diagnosis and treatment are crucial for better outcomes and reduced healthcare costs, yet awareness and funding remain insufficient.
Area of Science:
- Medical Science
- Public Health
Background:
- Chronic oedema/lymphoedema affects an estimated 300,000 Canadians.
- The condition is prevalent in up to 70% of breast and prostate cancer patients and 80% of individuals with morbid obesity.
- Lack of recognition and delayed treatment exacerbate the condition, leading to severe health complications and increased healthcare costs.
Purpose of the Study:
- To highlight the significant impact of chronic oedema/lymphoedema in Canada.
- To underscore the escalating healthcare costs associated with untreated cases.
- To address the disparity in diagnosis, treatment, and funding for this condition.
Main Methods:
- This study is a review of the current literature and healthcare landscape concerning chronic oedema/lymphoedema in Canada.
- Analysis of patient populations including cancer survivors and individuals with morbid obesity.
- Examination of the economic and health-related consequences of the disease.
Main Results:
- Chronic oedema/lymphoedema is progressive and leads to infection, disfigurement, disability, and potentially death if untreated.
- Delayed diagnosis and treatment significantly worsen patient prognosis and increase medical expenses.
- There is a notable disparity in diagnosis, treatment, and funding across Canada.
Conclusions:
- Increased public awareness and improved healthcare provider education on the aetiology and management of chronic oedema/lymphoedema are essential.
- Enhanced financial coverage for appropriate treatment methods and materials is necessary.
- Addressing these gaps is critical to improve patient outcomes and manage healthcare resource consumption effectively.
Related Concept Videos
01:12Chronic Inflammation: Introduction
41
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
41
01:18Pulmonary Edema II: Pathophysiology
39
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
39
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:16Lymphatic Vessels and Lymph Transport
13.6K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
13.6K
01:19Ascites
47
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
47